You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

Rexall Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for REXALL

REXALL has two approved drugs.



Summary for Rexall
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Rexall

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Rexall PREDNISONE prednisone TABLET;ORAL 080232-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try for Free ⤷  Try for Free
Rexall RESERPINE reserpine TABLET;ORAL 080637-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 2 of 2 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Rexall – Market Position, Strengths & Strategic Insights

In the highly competitive Canadian pharmaceutical retail market, Rexall has established itself as a significant player with a rich history and strategic positioning. This comprehensive analysis delves into Rexall's market position, strengths, and strategic insights, providing valuable information for industry professionals and stakeholders.

Rexall's Market Position

Rexall, one of Canada's largest pharmacy chains, operates 385 pharmacies across the country and employs approximately 8,000 people[1]. Founded in 1904, the company has a long-standing presence in the Canadian healthcare landscape[1]. Rexall's market position is characterized by its extensive network of stores and its focus on providing accessible healthcare services to Canadian communities.

Competitive Landscape

The Canadian drugstore marketplace is highly competitive, encompassing more than 10,200 pharmacies[2]. Rexall faces stiff competition from other major players, such as Shoppers Drug Mart, which claims to be Canada's leading pharmacy retailer with more than 1,300 locations[5].

Recent Developments

In a significant move, U.S. healthcare services giant McKesson has agreed to sell Rexall Pharmacy Group and online company Well.ca to private equity firm Birch Hill[1]. This transaction marks an important milestone in Rexall's corporate journey and could potentially reshape its market position.

"Birch Hill is committed to maintaining and investing in reliable, accessible healthcare services to expand Rexall's current network of pharmacies across Canada," Toronto-based Birch Hill said in a release[1].

Rexall's Strengths

Extensive Product Offerings

Rexall has expanded its offerings beyond traditional pharmacy services to include cosmetics, food, and everyday living products[2]. This diversification strategy allows Rexall to cater to a broader range of consumer needs and potentially increase foot traffic in its stores.

Strategic Partnerships

Rexall has demonstrated a keen ability to form strategic partnerships that enhance its product offerings and customer experience. For instance:

  1. The company has partnered with M&M Food Market in more than 250 stores, a relationship that has been successful for about a year and a half[10].
  2. Rexall has also formed a partnership with Staples, introducing over 200 Staples products in 317 Rexall locations across Canada[10].

Data-Driven Decision Making

Rexall leverages advanced geospatial data analytics to align its offerings with demand and optimize its real estate strategy. The company uses Precisely's Spectrum Spatial Insights solution to support site-selection decisions and evaluate the performance of existing stores[2].

Strategic Insights

Focus on Customer-Centric Approach

Rexall's partnerships and product diversification efforts reflect a strong focus on meeting customer needs. By bringing in well-known brands and expanding product categories, Rexall aims to enhance convenience for its customers and differentiate itself in the marketplace.

Leveraging Technology for Growth

The use of geospatial data analytics demonstrates Rexall's commitment to leveraging technology for strategic decision-making. This approach allows the company to:

  1. Optimize the deployment of development capital and real estate resources
  2. Evaluate the current portfolio of stores
  3. Identify key marketing and merchandising opportunities
  4. Understand growth potential market by market[2]

Adapting to Changing Market Dynamics

The recent sale of Rexall by McKesson to Birch Hill indicates a strategic shift. While the full implications of this deal are yet to be seen, it suggests that Rexall may be poised for a new phase of growth and development under new ownership.

Competitive Strategies

Differentiation Through Service Expansion

Rexall has been expanding its scope of care in response to changing consumer expectations. This strategy allows the company to differentiate itself from competitors and potentially capture a larger share of the healthcare services market.

Strategic Site Selection

For Rexall, site selection is business-critical. The company's real estate strategy involves a long-term commitment to each project, with a lead time of 18 to 24 months for opening a new pharmacy[2]. This careful approach to expansion helps ensure that new locations are positioned for success.

Continuous Performance Evaluation

Rexall leverages its predictive modeling capabilities to benchmark existing store performance on an ongoing basis. By comparing actual sales with model-generated projections, the company can identify outliers and take appropriate action to improve performance[2].

Future Outlook

The pharmaceutical retail landscape in Canada is likely to continue evolving, driven by factors such as changing consumer behaviors, technological advancements, and regulatory changes. For Rexall, key areas of focus may include:

  1. Further expansion of healthcare services
  2. Enhanced integration of digital and in-store experiences
  3. Continued optimization of store locations and formats
  4. Exploration of new partnerships to broaden product and service offerings

Key Takeaways

  1. Rexall is a major player in the Canadian pharmaceutical retail market, operating 385 pharmacies across the country.
  2. The company has recently been sold by McKesson to Birch Hill, potentially signaling a new phase of growth and development.
  3. Rexall's strengths include its extensive product offerings, strategic partnerships, and use of data-driven decision-making tools.
  4. The company's competitive strategies focus on differentiation through service expansion, strategic site selection, and continuous performance evaluation.
  5. Rexall's future outlook may involve further expansion of healthcare services, enhanced digital integration, and exploration of new partnerships.

FAQs

  1. How many stores does Rexall currently operate in Canada? Rexall operates 385 pharmacies across Canada[1].

  2. Who recently acquired Rexall? Private equity firm Birch Hill has agreed to acquire Rexall from U.S. healthcare services giant McKesson[1].

  3. What are some of Rexall's key strategic partnerships? Rexall has partnerships with M&M Food Market and Staples, introducing their products in numerous Rexall locations across Canada[10].

  4. How does Rexall use technology in its business operations? Rexall uses geospatial data analytics, specifically Precisely's Spectrum Spatial Insights solution, to support site-selection decisions and evaluate store performance[2].

  5. What sets Rexall apart from its competitors in the Canadian pharmacy market? Rexall differentiates itself through its expanded product offerings, strategic partnerships, data-driven decision-making, and focus on customer-centric services[2][10].

Sources cited: [1] https://www.costar.com/article/2000452147/mckesson-agrees-to-sell-one-of-canadas-largest-pharmacy-chains [2] https://www.precisely.com/app/uploads/2020/05/CS_Rexall_200506_E_final.pdf [5] https://www.marketscreener.com/quote/stock/MCKESSON-CORPORATION-13470/news/McKesson-Corporation-Reportedly-Seeks-Buyers-for-Canada-s-Rexall-Pharmacy-45735561/ [10] https://retail-insider.com/retail-insider/2020/09/drugstore-chain-rexall-retail-partnerships-diversify-store-offerings-mm-meats-staples/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.